Status:
COMPLETED
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD
Lead Sponsor:
Dey
Conditions:
COPD
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.
Eligibility Criteria
Inclusion
- Medical diagnosis of COPD
- Current or prior history of cigarette smoking
Exclusion
- Medical diagnosis of asthma
- Chest X-ray diagnostic of significant disease other than COPD
- Significant condition or disease other than COPD
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
End Date :
May 1 2007
Estimated Enrollment :
345 Patients enrolled
Trial Details
Trial ID
NCT00280371
Start Date
January 1 2006
End Date
May 1 2007
Last Update
November 11 2010
Active Locations (52)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Jasper, Alabama, United States, 35501
2
Research Site
Phoenix, Arizona, United States, 85006-2666
3
Research Site
Buena Park, California, United States, 90620
4
Research Site
Costa Mesa, California, United States, 92626